Allosteric egfr inhibitors and methods of use thereof
US-2025340535-A1 · Nov 6, 2025 · US
Heppner David is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Heppner David |
| Total patents | 16 |
| First publication | Dec 3, 2020 |
| Latest publication | Nov 6, 2025 |
Publications ranked by popularity score, then publication date.
US-2025340535-A1 · Nov 6, 2025 · US
US-2025340534-A1 · Nov 6, 2025 · US
US-12391671-B2 · Aug 19, 2025 · US
US-12377080-B2 · Aug 5, 2025 · US
US-2023406838-A1 · Dec 21, 2023 · US
US-2023212171-A1 · Jul 6, 2023 · US
US-11584746-B2 · Feb 21, 2023 · US
US-2022411404-A1 · Dec 29, 2022 · US
US-2022378757-A1 · Dec 1, 2022 · US
US-2022233545-A1 · Jul 28, 2022 · US
Latest publications not already listed above.
US-2021077469-A1 · Mar 18, 2021 · US
US-2021040088-A1 · Feb 11, 2021 · US
US-2020390783-A1 · Dec 17, 2020 · US
US-2020377477-A1 · Dec 3, 2020 · US
US-2020375999-A1 · Dec 3, 2020 · US
US-2020377501-A1 · Dec 3, 2020 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dana Farber Cancer Inst Inc | 16 |
| Scott David A | 1 |
| Gero Thomas | 1 |
| Beyett Tyler | 1 |
| Heppner David | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 16 |
| C07D401/14 | 11 |
| A61K45/06 | 11 |
| C07D471/04 | 10 |
| A61K31/506 | 9 |